Item 2.02. Results of Operations and Financial Condition.
See Item 7.01-Updated Financial Guidance below, which is incorporated by
reference herein.
Item 7.01. Regulation FD Disclosure.
Updated Financial Guidance
On January 11, 2022, Sotera Health Company (the "Company") issued a press
release announcing updated financial guidance for full-year 2021 revenue (the
"Press Release"). A copy of the Press Release is attached hereto as Exhibit
99.1.
This updated financial guidance is based on information available to the Company
as of January 11, 2022 and is subject to completion of the Company's year-end
financial closing procedures and audit by the Company's independent registered
public accounting firm.
J.P. Morgan Healthcare Conference Presentation
As previously announced, Michael B. Petras, Jr., Chairman and CEO of the
Company, will deliver a business update at the 40th Annual J.P. Morgan
Healthcare Conference on January 11, 2022 at 7:30 a.m. Eastern. A copy of the
Company's slide presentation is attached hereto as Exhibit 99.2 ("Conference
Presentation"). The Conference Presentation, and a link to the live presentation
or a replay of the webcast of the presentation, may also be accessed via the
Investor Relations section of the Company's website.
ESG Investor Engagement
From time to time on or after January 11, 2022, representatives of the Company
plan to conduct engagement with investors focused on environmental, social and
governance ("ESG") matters. A copy of the slide presentation representatives
will use in this engagement is attached hereto as Exhibit 99.3 ("ESG
Presentation"). A copy of the ESG Presentation is also accessible via the
Investor Relations section of the Company's website.
The information in Items 2.02 and 7.01, including Exhibits 99.1, 99.2, and 99.3,
is being furnished and shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to liability under that section, and shall not be deemed to be
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, unless expressly incorporated by specific
reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number             Description
99.1                         Press Release issued by Sotera Health Company, dated     January 11, 2022
99.2                         Sotera Health Company Conference Presentation
99.3                         Sotera Health Company ESG Presentation

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses